Flow cytometric assessment of endothelial and platelet microparticles in preeclampsia and their relation to disease severity and Doppler parameters

References

• Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scand J Immunol. 2007;66:159–65.
   PubMed Web of Science ®Google Scholar
• Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005;20:22–7.
   PubMed Web of Science ®Google Scholar
• Leroyer AS, Tedgui A, Boulanger CM. Role of microparticles in atherothrombosis. J Intern Med. 2008;263:528–37.
   PubMed Web of Science ®Google Scholar
• Banfi C, Brioschi M, Wait R, Begum S, Gianazza E, Pirillo A, et al. Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 2005;5:4443–55.
   PubMed Web of Science ®Google Scholar
• Peterson DB, Sander T, Kaul S, Wakim BT, Halligan B, Twigger S, et al. Comparative proteomic analysis of PAI-1 and TNF-α-derived endothelial microparticles. Proteomics 2008;8:2430–46.
   PubMed Web of Science ®Google Scholar
• Leroyer AS, Isobe H, Leseche G, Castier Y, Wassef M, Mallat Z, et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol. 2007;49:772–7.
   PubMed Web of Science ®Google Scholar
• Horstman LL, Jy W, Jimenez JJ, et al. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci. 2004;9:1118–35.
   PubMed Web of Science ®Google Scholar
• Preston RA, Jy W, Jimenez JJ, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003;41:211–7.
   PubMed Web of Science ®Google Scholar
• Koga H, Sugiyama S, Kugiyama K, et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2005;45:1622–30.
   PubMed Web of Science ®Google Scholar
• Bernal-Mizrachi L, Jy W, Jimenez JJ, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J. 2003;145:962–70.
   PubMed Web of Science ®Google Scholar
• Heloire F, Weill B, Weber S, et al. Aggregates of endothelial microparticles and platelets circulate in peripheral blood. Variations during stable coronary disease and acute myocardial infarction. Thromb Res. 2003;110:173–80.
   PubMed Web of Science ®Google Scholar
• Jimenez JJ, Jy W, Mauro LM, et al.. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol. 2001;112:81–90.
   PubMed Web of Science ®Google Scholar
• Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005;16:3381–8.
   PubMed Web of Science ®Google Scholar
• Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost. 2006;4:566–73.
   PubMed Web of Science ®Google Scholar
• Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002;51:2840–5.
   PubMed Web of Science ®Google Scholar
• Pihusch V, Rank A, Steber R, Pihusch M, Pihusch R, Toth B, et al.. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients. Transplantation 2006;81:1405–9.
   PubMed Web of Science ®Google Scholar
• Nomura S, Ishii K, Inami N, Kimura Y, Uoshima N, Ishida H, et al. Evaluation of angiopoietins and cell-derived microparticles after stem cell transplantation. Biol Blood Marrow Transplant. 2008;14:766–74.
   PubMed Web of Science ®Google Scholar
• Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol. 2001;115:451–9.
   PubMed Web of Science ®Google Scholar
• McNiff JM, Kaplan DH. Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus. J Cutan Pathol. 2008;35:452–6.
   PubMed Web of Science ®Google Scholar
• Walsh SW, Vaughan JE, Wang Y, et al. Placental isoprostane is significantly increased in pre-eclampsia. FASEB J. 2000;14:1289–96.
   PubMed Web of Science ®Google Scholar
• Granger JP, Alexander BT, Llinas MT, et al. Pathophysiology of hypertension during pre-eclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001;38(3):718–28.
   PubMed Web of Science ®Google Scholar
• Arias F. Accuracy of the middle-cerebral-to-umbilical-artery resistance index ratio in the prediction of neonatal outcome in patients at high risk for fetal and neonatal complications. Am J Obstet Gynecol. 1994;171(6):1541–5.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Quintero VH, Jimenez JJ, Smarkusky LP, Mauro LM, Jy W, Hortman L, et al. Elevated plasma endothelial microparticles: pre-eclampsia versus gestational hypertension. Am J Obstet Gynecol. 2004;191:1418–24.
   PubMed Web of Science ®Google Scholar
• Mallat Z, Banamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, et al. Elevated levels of shed membrane microparticles in procoagulant potential in the peripheral circulating blood of patients with acute coronary syndrome. Circulation 2000;101:841–3.
   PubMed Web of Science ®Google Scholar
• Proulle V, Hugel B, Guillet B, Grunebaum L, Lambert T, Freyssinet JM, et al.: Circulating microparticles are elevated in haemophiliacs and non-haemophilic individuals aged <18 years. Br J Haematol. 2005;131:487–9.
   PubMed Web of Science ®Google Scholar